Drug intelligence / Profile preview

ilon Salbe classic

Development stage: Unknown
Lead developer: Cesra
Modality: Small Molecules
Administration: Topical

Overview

ilon Salbe classic is a traditional herbal ointment developed by Cesra Arzneimittel for the treatment of localized, purulent skin inflammations. Its active formulation consists of larch turpentine, turpentine oil (maritime pine type), and eucalyptus oil. Functioning as a "drawing ointment" (Zugsalbe), it possesses antiseptic properties and promotes blood circulation in the affected area to facilitate the resolution of infections such as folliculitis, pustules, and sweat gland inflammations. It is available as an over-the-counter product in Germany and is currently being evaluated in Phase IV clinical trials for acute folliculitis.

Brand names: ilon Salbe classic
Other names: ilon Salbe

Beyond the preview

Go deeper on ilon Salbe classic.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ilon Salbe classic.

Explore the full profile